A scholarly study of corruption in the larger context of societal growth and development Corruption is no longer a word and has become a noise. Debates on corruption have reached high decibel levels and the world is no closer to solutions. Given the complexity, there are as many views as there are participants. Some speak from high moral pedestals like those from the rich, donor countries. It is no surprise that...

-The Economic Times School textbooks will not feature any 'offensive' political cartoon, the government assured on Monday, days after a 1949 cartoon of Dalit icon Ambedkar in a political science text rocked Parliament. The government has ordered an inquiry to identify NCERT officials responsible for inclusion of the Ambedkar cartoon in the textbook, HRD minister Kapil Sibal said in the Lok Sabha. "I found that a number of cartoons were inappropriate...a review...

On February 9, 2010, the then Minister of Environment and Forests, Government of India, Jairam Ramesh, imposed an indefinite moratorium on the introduction of Bt Brinjal in India. It is necessary and desirable to quote the order verbatim. It reads as follows: It is my duty to adopt a cautious, precautionary based approach and impose a moratorium on the release of Bt Brinjals till such time independent scientific studies establish, to...

-The Hindustan Times In April, after yet another story of maid abuse came out in the open, a news magazine ran a cover story titled, ‘The new slaves’. While many would cringe at the thought of equating domestic workers with slaves, unfortunately that is exactly how many families treat their domestic help, taking advantage of a crowded labour market, lack of a credible support system for the help, weak implementation of...

-PTI German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week. Bayer Pharma has not given its consent to Cipla to launch its generic Sorafenib (sold under the brand name Nexavar) and the company’s decision to cut the price of the life-extending kidney and liver cancer drug “is a clear...